InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000075 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28+ MET GAUSTER STEPHEN W EVP, GC F - Tax $71.68 -19.4K 54.7K -26% -$1.39M
DM 2023-03-02 2023-02-28 MET GAUSTER STEPHEN W EVP, GC A - Grant — +34.8K 71.9K +94% —
D 2023-03-02 2023-02-28 MET GAUSTER STEPHEN W EVP, GC A - Grant $0.00 +11.1K 11.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 2,176 $71.27 52,503 D — —
2 Common Common Stock 2023-02-28 A A 3,712 — 40,835 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2023-02-28 A A 31,044 — 71,879 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Common Common Stock 2023-02-28 F D 17,200 $71.73 54,679 D — —
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 11,136 $0.00 11,136 D $71.73 · — to 2033-02-27 11,136 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.